| 000 | 02611nam a2200313Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625124711.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-7983 | ||
| 245 | 1 | 0 | _aIntracerebroventricular delivery of dominant negative prion protein in a mouse model of iatrogenic Creutzfeldt-Jakob disease after dura graft transplantation |
| 490 | 0 | _vNeuroScience Letters, 402(3), p.222-226, 2006 | |
| 520 | 3 | _aWe have developed a novel procedure in which a small collagen sheet (3mm×3 mm)absorbing prion-infected brain homogenates was transplanted onto the brain surface of highly prion-susceptible transgenic mice (Tg(MoPrP)4053/FVB), as an animal model of iatrogenic Creutzfeldt- Jakob disease (iCJD)caused by prion-contaminated cadaveric dura graft transplantation. Using the iCJD model, we further investigated the in vivo efficacy of dominant negative recombinant prion protein with lysine substitution at mouse codon 218 (rPrP-Q218K), which is known to inhibit prion replication in vitro (H. Kishida, Y. Sakasegawa, K. Watanabe, Y. Yamakawa, M. Nishijima, Y. Kuroiwa, N.S. Hachiya, K. Kaneko, Non-glycosylphosphatidylinositol (GPI)-anchored recombinant prion protein with dominant-negative mutation inhibits PrPSc replication in vitro, Amyloid, vol. 11, 2004, pp. 14-20.). Following 7-day intracerebroventricular administration of the rPrP-Q218K via an indwelling catheter connected to the implanted osmotic pump, the median incubation period of Tg(MoPrP)4053/FVB was prolonged considerably from 117 days to 131 days (p = 0.016, log-rank test)in the rPrP-Q218K-treated group, even after a lengthy latency period of as long as 30 days by starting the rPrP-Q218K injection. Whether wild-type rPrP, other mutant rPrPs, or the combination of rPrP-Q218K with other anti-prion compounds might extend the survival period in that condition must be further investigated. | |
| 650 | 1 | 4 | _aIATROGENIC CREUTZFELDT-JAKOB DISEASE (ICJD) |
| 650 | 1 | 4 | _aANIMAL MODEL OF ICJD |
| 650 | 1 | 4 | _aOSMOTIC PUMP |
| 650 | 1 | 4 | _aHIGHLY PRION-SUSCEPTIBLE TRANSGENIC MICE (TG(MOPRP)4053/FVB) |
| 650 | 1 | 4 | _aDOMINANT NEGATIVE RECOMBINANT PRION PROTEIN (RPRP-Q218K) |
| 700 | 1 | 2 | _aFuruya, N. |
| 700 | 1 | 2 | _aKawahara, N. |
| 700 | 1 | 2 | _aYamakawa, Y. |
| 700 | 1 | 2 | _aKishida, H. |
| 700 | 1 | 2 | _aHachiya, N.S. |
| 700 | 1 | 2 | _aNishijima, M. |
| 700 | 1 | 2 | _aKirino, T. |
| 700 | 1 | 2 | _aKirino, T. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1W6G9-CG5-1i2ByhLe9u6pL_ddhCz_5vB/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c42295 _d42295 |
||